Exhibit 107
Calculation of Filing Fee Tables
S-3
(Form Type)
ADC Therapeutics SA
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit (1) | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial Effective Date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |
Newly Registered Securities | ||||||||||||
Fees to be Paid | Equity | Common Shares | 457(c) | 27,726,052 (2) | $2.855 | $79,157,878.46 | 0.00015310 | $12,119.07 | ||||
Fees Previously Paid | — | — | — | — | — | — | — | |||||
Carry Forward Securities | ||||||||||||
Carry Forward Securities | — | — | — | — | — | — | — | — | — | |||
Total Offering Amounts | $79,157,878.46 | $12,119.07 | ||||||||||
Total Fees Previously Paid | $0 | |||||||||||
Total Fee Offsets | $0 | |||||||||||
Net Fee Due | $12,119.07 |
(1) Pursuant to Rule 457(c) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share is the average of the high and low sale prices for common shares as reported on the New York Stock Exchange on June 24, 2025.
(2) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended, the Registrant is also registering hereunder an indeterminate number of common shares that may be issued in connection with anti-dilution provisions or stock splits, stock dividends or similar transactions.